Alberto Vaiarelli

ORCID: 0000-0002-0873-3925 · 27 papers in corpus
observational 2026
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-026-03961-8

PURPOSE: To evaluate whether the outcomes and characteristics of a first IVF/ICSI cycle are associated with embryological and clinical outcomes in a subsequent cycle performed within 2 years. METHODS: This retrospective single-center obser…

observational 2026
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-026-03910-5

PURPOSE: To evaluate whether artificial endometrial preparation using hormone replacement therapy (HRT) influences clinical and neonatal outcomes compared with modified natural cycles (mNC) in single euploid vitrified-warmed blastocyst tran…

observational 2026
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03722-z

PURPOSE: To identify treatment-related factors influencing low oocyte maturation rates in standard ovarian stimulation (OS) cycles and patients' candidates for clinical studies on rescue-IVM. METHODS: Retrospective study including retrieva…

observational 2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1854570

AIMS: To evaluate DuoStim strategy across a decade from its clinical implementation in IVF by comparing embryological and clinical outcomes between the first and second ovarian stimulations (1st-OS and 2nd-OS) conducted within 30 days, focu…

observational 2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03317-0

PURPOSE: This study is to evaluate the effectiveness of a PPOS protocol in poor prognosis patients undergoing IVF with DuoStim and PGT-A versus the conventional protocol with GnRH antagonist. METHODS: Retrospective cohort study encompassin…

observational 2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03396-7

PURPOSE: To evaluate the performance of different embryo transfer (ET) operators in a strictly controlled scenario minimizing potential confounders. METHODS: This single-center retrospective cohort study analyzed vitrified-warmed single eu…

observational 2025
Andrology ·doi:10.1111/andr.13811

OBJECTIVE: To examine the association between semen parameters, assessed according to World Health Organization (WHO)-2021 criteria, and paternal body mass index (BMI) and age, with embryological and clinical outcomes in ICSI cycles involvi…

guideline 2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03379-0

PURPOSE: Obesity is increasingly at the center of modern international healthcare systems. This is a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) aimed at evaluating the impact of…

observational 2024
Human Reproduction ·doi:10.1093/humrep/deae040

STUDY QUESTION: What are the clinical pregnancy and live birth rates in women who underwent up to two more euploid blastocyst transfers after three failures in the absence of another known factor that affects implantation? SUMMARY ANSWER: …

guideline 2024
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03197-4

PURPOSE: This position statement by the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) aims to establish an optimal framework for fertility preservation outside the standard before oncological therapies. Key…

review 2023
Human Reproduction Update ·doi:10.1093/humupd/dmac031

BACKGROUND: Folliculogenesis occurs in the highly dynamic environment of the ovary. Follicle cyclic recruitment, neo-angiogenesis, spatial displacement, follicle atresia and ovulation stand out as major events resulting from the interplay b…

review 2023
Journal of Endocrinological Investigation ·doi:10.1007/s40618-022-02000-4

BACKGROUND: Infertility, which is defined as the inability to conceive after at least 12 months of regular unprotected sexual intercourses, affects about 15-20% of couples worldwide and a male factor is involved in about half of the cases. …

observational 2023
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-022-02684-w

PURPOSE: An impact of different gonadotrophins selection for ovarian stimulation (OS) on oocyte competence has yet to be defined. In this study, we asked whether an association exists between OS protocol and euploid blastocyst rate (EBR) pe…

review 2022
Nutrients ·doi:10.3390/nu14091918

Increasing evidence on the significance of nutrition in reproduction is emerging from both animal and human studies, suggesting a mutual association between nutrition and female fertility. Different "fertile" dietary patterns have been stud…

other 2022
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-022-02409-z

PURPOSE: Our primary objective was to assess whether immediately undergoing a second stimulation in the same ovarian cycle (DuoStim) for advanced-maternal-age and/or poor-ovarian-reserve (AMA/POR) patients obtaining ≤ 3 blastocysts for prei…

observational 2021
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.11.024

OBJECTIVE: To evaluate the true impact of endometriosis on oocytes' competence defined as blastulation, euploidy and implantation rates. DESIGN: Retrospective multicenter case-control study involving infertile couples undergoing ICSI with …

review 2021
Journal of visualized experiments : JoVE ·doi:10.3791/61963

Preserving female fertility is crucial in a multifunctional healthcare system that takes care of patients' future quality of life. Oocyte cryopreservation is recognized by several international scientific societies as the gold standard for …

review 2021
·doi:10.3791/61963-v

Preserving female fertility is crucial in a multifunctional healthcare system that takes care of patients' future quality of life. Oocyte cryopreservation is recognized by several international scientific societies as the gold standard for …

other 2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00605-z

The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Global…

other 2020
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-019-01607-6

PURPOSE: To detect putative differences in the miRNomic profile of follicular fluids collected after follicular-phase-stimulation (FPS-FFs) and paired luteal-phase-stimulation (LPS-FFs) in the same ovarian cycles (DuoStim). METHODS: Explor…

review 2020
Therapeutic advances in reproductive health ·doi:10.1177/2633494120941480

Despite the considerate progress to which assisted reproduction technology (ART) has been subject since 1978, some issues remain unresolved. Notably, the clinical management of patients with a poor ovarian response is still a challenge in e…

review 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00094

Advanced maternal age (AMA; >35 year) is associated with a decline in both ovarian reserve and oocyte competence. At present, no remedies are available to counteract the aging-related fertility decay, however different therapeutic approache…

review 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00398

The purpose of a pharmacogenomic approach is to tailor treatment on the basis of an individual human genotype. This strategy is becoming increasingly common in medicine, and important results have been obtained in oncologic and antimicrobia…

review 2019
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2019.1603289

At present, infertility is a key-issue. When applicable, in vitro fertilization (IVF) has become the standard approach to treat this condition but a thorough investigation and, whenever possible, the individual diagnosis of the underlying c…

observational 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00917

This multicenter study evaluated the reliability of the recently published ART calculator for predicting the minimum number of metaphase II (MII) oocytes (MIImin) to obtain at least one euploid blastocyst in patients undergoing in vitro fer…